COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
NATIONALLY RANKED ROSEN LAW FIRM Encourages Fisker Inc. Investors with Losses to Secure Counsel Before Important January 26 Deadline in Securities Class Action - FSR
Rosen Law Firm, a globally recognized investor rights law firm, is encouraging Fisker Inc. investors who have suffered losses between August and November 2023 to seek legal counsel before the upcoming January 26, 2024 deadline in the securities class action. The firm, with a history of successful securities class action settlements, advises investors to carefully select qualified counsel to represent their interests. The lawsuit alleges that Fisker made materially false and misleading statements, leading to investor damages. Investors can find more information about joining the class action on the Rosen Law Firm's website or by contacting their legal team directly. -
COMMUNIQUÉ DE PRESSE
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Dollar General Corporation Investors to Secure Counsel Before Important January 26 Deadline in Securities Class Action - DG
The Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dollar General Corporation about the January 26, 2024 lead plaintiff deadline. If you've purchased Dollar General common stock during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. For more information on the class action and how to join, visit the provided website or contact the firm directly. The Rosen Law Firm has a solid track record in securities class actions and shareholder derivative litigation, and represents investors globally. -
COMMUNIQUÉ DE PRESSE
NATIONALLY RANKED ROSEN LAW FIRM Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EGRX
Read the latest press release by the Rosen Law Firm, a leading global investor rights law firm, reminding Eagle Pharmaceuticals, Inc. investors of an important deadline in a securities class action. Learn how to join the class action and seek compensation without out-of-pocket fees. The lawsuit alleges that Eagle Pharmaceuticals made misleading statements and failed to disclose adverse facts, leading to investor damages. Contact the firm for more information on the class action or visit their website for updates on the case. -
COMMUNIQUÉ DE PRESSE
ROSEN, A LONGSTANDING LAW FIRM, Encourages Dada Nexus Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - DADA
The Rosen Law Firm, a leading global investor rights law firm, encourages Dada Nexus Limited investors to seek legal counsel before the upcoming March 11, 2024 deadline in the securities class action it has filed. Investors who purchased Dada securities between May 11, 2023 and January 8, 2024 may be entitled to compensation. Rosen Law Firm, known for its successful track record in securities class actions and shareholder derivative litigation, emphasizes the importance of selecting qualified counsel for this case. For more information, investors can visit the Rosen Law Firm's website or contact its attorneys directly. The lawsuit alleges that Dada Nexus Limited made materially false or misleading statements throughout the Class Period, leading to damages suffered by investors when the true details entered the market. -
COMMUNIQUÉ DE PRESSE
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CMI
The Rosen Law Firm, a leading global investor rights law firm, has filed a class action lawsuit on behalf of Cummins Inc. investors. The lawsuit concerns alleged misrepresentations and omissions by Cummins Inc. regarding issues with its engines. Investors who purchased Cummins securities during a specific period may be entitled to compensation and are encouraged to seek qualified counsel before the important deadline. The Rosen Law Firm has a strong track record in securities class actions and has achieved sizable settlements for investors in the past. -
COMMUNIQUÉ DE PRESSE
ROSEN, A LEADING NATIONAL FIRM, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important January 29 Deadline in Securities Class Action - CHPT
Rosen Law Firm, a leading national firm, encourages ChargePoint Holdings, Inc. investors to secure counsel before the January 29 deadline in a securities class action. The class action lawsuit alleges that the defendants made materially false and/or misleading statements that impacted ChargePoint's profitability. Investors who purchased ChargePoint securities during the specified period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm represents investors globally and has achieved significant success in securities class action settlements. For more information on the class action, individuals can visit the Rosen Legal website or contact the firm directly. -
COMMUNIQUÉ DE PRESSE
Pancho Soekoro's Inspirational Journey to Success with Panca Salon
Discover the inspiring journey of Pancho Soekoro, founder and CEO of Panca Salon, as he reflects on the challenges and triumphs that have shaped one of the most successful salon chains in the region. From humble beginnings to becoming a beacon in the beauty industry, Panca Salon is synonymous with quality, innovation, and a commitment to excellence. Learn about the commitment to excellence, community giving, and plans for the future in this exclusive press release. -
COMMUNIQUÉ DE PRESSE
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
The Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of BioNTech SE investors who purchased securities between March 30, 2022 and October 13, 2023. Investors who wish to serve as lead plaintiff must act before March 12, 2024. The lawsuit alleges that BioNTech and Pfizer Inc. made false and misleading statements regarding the demand for their COVID-19 vaccine, resulting in damages for investors. For more information or to join the class action, visit the Rosen Law Firm's website. -
COMMUNIQUÉ DE PRESSE
ROSEN, NATIONAL TRIAL LAWYERS, Encourages The Estee Lauder Companies Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EL
The Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Estée Lauder Companies Inc. (NYSE: EL) of the important February 5, 2024 lead plaintiff deadline in the securities class action. Investors who purchased Estée Lauder securities during the Class Period may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Complaint alleges that during the Class Period, defendants misled investors with unrealistic and materially false statements about market demand regarding Estée Lauder’s products, as well as supply chain issues and mismanagement of inventory levels in Asia and the United States. To join the Estée Lauder class action, go to the provided website or contact the Rosen Law Firm for more information.
